Company intelligence / Profile preview
N&N Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
Overview
N&N Pharmaceuticals is an active, privately held biopharmaceutical company based in Montgomery County, Maryland. The company’s lead drug candidate, North-methanocarbathymidine (N-MCT), is a novel small molecule antiviral that has entered Phase 1 clinical trials in the U.S. and received Orphan Drug Designation from the FDA for neonatal herpes simplex virus infection. Preclinical data suggest superior activity against shingles compared to existing therapies. Clinical development is ongoing in both the U.S. and Asia.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on N&N Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N&N Pharmaceuticals.